Pancreas transplantation

1. The Role of Pancreas
Transplantation in the Long Term
Management of Diabetes
Christopher Johnson MD
Professor of Surgery
Division of Transplant Surgery
Medical College of Wisconsin
Brought to you by

2. Learning objectives:
1. This talk will increase your understanding about the
rationale (including risk/benefit assessment) for
pancreas transplantation in the management of
diabetes.
2. This talk will allow you to better appreciate some of
technical and immunological challenges associated
with pancreas transplantation
3. This talk will help you to better anticipate therapy
options for diabetic patients who have chronic kidney
disease. Brought to you by

3. no disclosures
Brought to you by

4. Tight control reduces end organ damage
but increases the risk (2-3 fold) of
severe hypoglycemic episodes (1).
1 DCCT. The Diabetes Control and
Complications Trial Research Group The
Effect of Intensive Treatment of Diabetes
on the Development and Progression of
Long-Term Complications in Insulin-
Dependent Diabetes Mellitus. N Engl J
Med 1993; 329: 977–986.
Brought to you by

5. DCCT trial (1441 patients randomized to intensive
insulin vs. conventional insulin) designed to
examine the effect of tight control on 2°
complications (followed > 6yrs)
Retinopathy Neuropathy
Incidence progression Prevalence of neuropathy
Brought to you by

6. A successful pancreas transplant
completely normalizes blood sugar
control
However, it requires life long immunosuppression
Brought to you by

7. Types of pancreas transplants:
 Kidney/Pancreas (pts undergoing kidney
transplantation)
 Pancreas after kidney (already on IS)
 Pancreas transplant alone (severe life-
threatening complications of DM)
 Islet after kidney (no surgical procedure)
 Islet transplant (no surgical procedure but
requires IS)
Brought to you by

8. Combined kidney/pancreas transplant is
the most common scenario for pancreas
transplantation:
Brought to you by

9. Indications for Simultaneous Kidney
and Pancreas Transplant:
 Presence of ESRD (or eGFR < 20 ml/min)
 Presence of diabetes: type 1 or 2 (meeting
age (< 55) and BMI criteria (<30)
 Lack of major complications and/or severe
cardiovascular disease which limits life
expectancy
Brought to you by

10. Figure 13: Unadjusted 1-year, 3-year, 5-year and 10-year
pancreas graft survival by transplant type
Brought to you by

11. Reversal of Lesions of Diabetic Nephropathy after Pancreas
Transplantation
Fioretto, Paola; Steffes, Michael W.; Sutherland, David E.R.; Goetz, Frederick C.; Mauer,
Michael.
NEJM 339:69-75 July 9, 1998 Number 2
Brought to you by

12. Survival estimates for patients with kidney graft function at 1 year.
Abbreviations: LD, living donor; CAD, cadaveric.
Long-term survival following simultaneous kidney-pancreas
transplantation versus kidney transplantation alone in patients
with type 1 diabetes mellitus and renal failure
Am J Kid Disease 41:464-470. 2003
Brought to you by

13. Figure 2: Waiting list death rates by
diagnosis, 1999–2008.
Brought to you by

14. Diabetics who receive k/p gain more life-
years than k-alone or non-diabetics:
Brought to you by

15. k/p transplants are equally successful for type 1
and type 2 diabetes:
data from SRTR
2010
Brought to you by

16. What is the role of pancreas
transplant in type 2 diabetes?
 Diabetes affects 10% of the population
 90-95% is type 2
 Distinction between type 1 and 2 not
always clear cut
cC –peptide is not accurate in renal failure
Brought to you by

17. suggested criteria:
Brought to you by

18. Brought to you by

19. Organ Procurement: Simultaneous Liver and
Pancreas Removal
Brought to you by

20. Back table dissection:
Brought to you by

21. More back table dissection…
Brought to you by

22. Back table Reconstruction of Pancreatic Allograft
Brought to you by

23. Arterial “Y” Graft of Donor Iliac Artery
Portal Vein Mobilization
Brought to you by

24. Bladder Drainage with Systemic Venous
Anastomosis
Enteric Drainage with Portal Venous
Anastomosis
Brought to you by

25. Trends in maintenance immunosuppression therapy prior to
discharge for simultaneous kidney-pancreas
transplantation 1994-2003
American Journal of Transplantation 2005;5(Part 2):874-886
Brought to you by

26. Incidence of rejection during first year among simultaneous
kidney-pancreas recipients
American Journal of Transplantation 2005;5(Part 2):874-886
Brought to you by

27. ADVANCES IN PANCREAS TRANSPLANTATION.
Transplantation. 77(9) Supplement:S62-S67, May 15, 2004.
Burke G, Ciancio G, Sollinger H
Brought to you by

28. Post-Transplant Complications
•Early post-operative complications (Bleeding, infection)
•Venous Thrombosis
•Reperfusion pancreatitis
•Pancreas is a relatively low-flow organ
•Unrecognized inherited hypercoagulable state
in the recipient
•Transplant Pancreatitis
•Mild - transient amylase elevation for 48-96h
•Severe – fat necrosis, infected peripancreatic fluid
•Kidney (urine leak, ureteral stricture)
Surgical Aspects of Pancreas Transplantation:
Brought to you by

29. Radiologic tools for transplant
evaluation:
Brought to you by

30. Splenic vein thrombosis:
Brought to you by

31. Fluid collection on CT:
Brought to you by

32. Drachenberg CB, Papadimitriou JC, Klassen DK, et.al: Evaluation of pancreas transplant needle biopsy.
Reproducibility and revision of histologic grading system. Transplantation 1997;63(11):1579-1586.
Drachenberg C, Klassen D, Bartlett S, Hoehn-Saric E, Schweitzer E, Johnson L, Weir J and Papadimitriou J:
Histologic grading of pancreas acute allograft rejection in percutaneous needle biopsies.
Transplant Proc 1996;28(1):512-513
Diagnosis of Pancreatic Allograft Rejection (is difficult)
Brought to you by

33. Brought to you by

34. PAK and PTA have higher rate of
immunologic graft loss after 1 year

35. Indications for isolated pancreas
transplant (PAK or PTA):
 Frequent and/or severe hypoglycemic
events
 consistent failure of insulin-based
management to prevent acute and chronic
complications (poor control).
 clinical and/or emotional problems
associated with the use of exogenous
insulin therapy that are so severe as to be
incapacitating Brought to you by

36. Isolated Pancreas Transplant: Recipient
Selection Criteria
IDDM, age > 18 years with an upper age limit of ?
Ability to withstand surgery and immunosuppression
Psychosocial stability/ social support/ compliance/
 commitment to long-term follow-up
Diabetic secondary complications
Hyper-lability/ Hypoglycemic Unawareness
Financial resources (USA)
Absence of any exclusionary criteria:
- renal function
- coronary disease
Brought to you by

37. Mortality risk/benefit of PAK and PTA:
American Journal of Transplantation 2004; 4:
2018–2026
Mortality on waiting list: Mortality after transplant:
spkSPK
Brought to you by

38. Islet Isolation
1. Organ Procurement
2. Distension with
Collagenase
3. Digestion & Mechanical
Separation
4. Purification of Islets
5. Quantification
Brought to you by

39. Brought to you by

40. Brought to you by

41. Brought to you by

42. Brought to you by

43. Brought to you by

44. The “Edmonton Protocol”
 Efficient Isolation Procedure
 Reliable Collagenase
 Steroid Free Immunosuppressive
Protocol
 IL-2R Blockade
 Tacrolimus
 Sirolimus
Brought to you by

45. Only 31% remained
insulin independent at 2
years
N Engl J Med 2006;355:1318-30.
Brought to you by

46. Failed islet transplants are associated
with sensitization to HLA antigens:
Brought to you by

47. Whole Pancreas Transplantation
+ +
Pancreatic Islet Cell Transplantation
Brought to you by

48. Brought to you by

49. Successful islet transplants decrease
progression of nephropathy and retinopathy
Preservation of renal
function
Decreased progression of
retinopathy
Brought to you by

50. Conclusions:
 Pancreas transplants when successful, normalize
glucose metabolism and increase quality (and
quantity) of life.
 “Good risk” diabetics (type 1 or 2) with renal failure
should receive either a living donor kidney transplant
or a combined kidney/pancreas transplant
Brought to you by

51. Conclusions:
 “Good risk” diabetics with a functioning
kidney transplant (and problematic BS
control) should be considered for pancreas
after kidney
 “Better risk” diabetics without kidney
disease, but with life threatening
manifestations should be considered for
pancreas transplant alone
“Good” = age < 55, BMI < 30, insulin use
< 1U/kg/day, no or minimal CAD, PVD
Brought to you by

52. This platform has been started by
Parveen Kumar Chadha with the
vision that nobody should suffer
the way he has suffered because of
lack and improper healthcare
facilities in India. We need lots of
funds manpower etc. to make this
vision a reality please contact us.
Join us as a member for a noble
cause.
Brought to you by

53. 011-25464531, 011-41425180, 011-66217387
+91-9818308353,+91-9818569476
othermotherindia@gmail.com
www.other-mother.in
https://www.facebook.com/pages/Other-Mother-Nursing-Crusade/224235031114989?ref=hl
http://www.linkedin.com/profile/view?id=326103341&trk=nav_responsive_tab_profile
https://twitter.com/othermotherindi
https://cparveen.wix.com/other-mother
A WORLDWIDE MISSITION
Contact Us:-
JOIN US